Range Low Price High Price Comment
30 days $20.00 $20.00 Wednesday, 15th Apr 2020 ARQL stock ended at $20.00. During the day the stock fluctuated 0% from a day low at $20.00 to a day high of $20.00.
90 days $20.00 $20.00
52 weeks $5.76 $20.45

Historical ArQule prices

Date Open High Low Close Volume
Feb 12, 2016 $1.65 $1.65 $1.65 $1.65 31 500
Feb 11, 2016 $1.66 $1.66 $1.66 $1.66 26 000
Feb 10, 2016 $1.61 $1.61 $1.61 $1.61 93 300
Feb 09, 2016 $1.63 $1.63 $1.63 $1.63 82 700
Feb 08, 2016 $1.65 $1.65 $1.65 $1.65 84 300
Feb 05, 2016 $1.64 $1.64 $1.64 $1.64 94 400
Feb 04, 2016 $1.69 $1.69 $1.69 $1.69 66 600
Feb 03, 2016 $1.69 $1.69 $1.69 $1.69 68 300
Feb 02, 2016 $1.73 $1.73 $1.73 $1.73 14 400
Feb 01, 2016 $1.76 $1.76 $1.76 $1.76 26 100
Jan 29, 2016 $1.75 $1.75 $1.75 $1.75 74 000
Jan 28, 2016 $1.73 $1.73 $1.73 $1.73 76 500
Jan 27, 2016 $1.77 $1.77 $1.77 $1.77 44 100
Jan 26, 2016 $1.81 $1.81 $1.81 $1.81 46 100
Jan 25, 2016 $1.82 $1.82 $1.82 $1.82 51 000
Jan 22, 2016 $1.81 $1.81 $1.81 $1.81 32 300
Jan 21, 2016 $1.79 $1.79 $1.79 $1.79 39 300
Jan 20, 2016 $1.83 $1.83 $1.83 $1.83 96 900
Jan 19, 2016 $1.79 $1.79 $1.79 $1.79 79 100
Jan 15, 2016 $1.78 $1.78 $1.78 $1.78 97 600
Jan 14, 2016 $1.86 $1.86 $1.86 $1.86 81 800
Jan 13, 2016 $1.86 $1.86 $1.86 $1.86 104 500
Jan 12, 2016 $1.89 $1.89 $1.89 $1.89 74 800
Jan 11, 2016 $1.91 $1.91 $1.91 $1.91 126 500
Jan 08, 2016 $2.00 $2.00 $2.00 $2.00 155 300
Click to get the best stock tips daily for free!

About ArQule

ArQule ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase III clinical trial for the treatment of liver cancer and non-small cell lung cancer; Phase II clinical trial for the treatment of mesotheli... ARQL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT